The Truth About the Impact Factor of International Journal of Infectious Diseases
Let me start with something that might surprise you: the International Journal of Infectious Diseases (IJID) has an impact factor that sits somewhere between "respectable" and "solid." But here's what most researchers don't realize when they're deciding where to submit their work — the impact factor alone tells you almost nothing about whether your paper will actually be read, cited, or make a real difference in the field Worth keeping that in mind..
I know, I know. We've all been conditioned to treat impact factors like academic currency. But let me break down what the IJID's impact factor actually means, and more importantly, what it doesn't mean.
What Is the International Journal of Infectious Diseases?
The International Journal of Infectious Diseases isn't just another medical journal that happened to add "international" to its name for SEO purposes. It's actually one of the more established publications in the infectious disease space, founded in 1997 and published by Elsevier. The journal covers a genuinely broad scope — everything from emerging viral outbreaks to antibiotic resistance patterns to vaccine efficacy studies.
The Geographic Reality
Here's something worth knowing: despite the "international" in its title, IJID has strong roots in Asia and the developing world. On top of that, this isn't a criticism — it's actually one of its strengths. While Western journals often focus heavily on diseases prevalent in developed nations, IJID regularly publishes research on tropical diseases, neglected tropical diseases, and infectious threats that affect billions of people globally.
The journal's editorial board reflects this geographic diversity, with contributors from countries you don't see represented in many top-tier Western medical journals. This matters because it means the research published here often addresses questions that are overlooked elsewhere.
Why It Matters for Researchers
So why should you care about IJID's impact factor? Well, it depends entirely on what you're trying to accomplish.
If you're an early-career researcher building your publication record, the impact factor still carries weight in tenure and promotion decisions, even though many senior academics will privately admit it's a flawed metric. If you're established and just want your work to reach the right audience, the impact factor becomes less relevant than the journal's actual readership and citation patterns.
The Real-World Impact
Here's what most people miss: IJID's impact factor, which hovers around 5.0 in recent years, puts it solidly in the second tier of infectious disease journals. Practically speaking, 0-6. Day to day, that's not a knock — it's respectable. But it also means your paper won't get the automatic visibility boost that comes with publishing in a journal with an impact factor above 10.
On the flip side, and this is important, IJID has carved out a niche where papers on region-specific infectious diseases, public health interventions in resource-limited settings, and emerging disease surveillance often get more attention than they would in higher-impact general medical journals. Sometimes niche impact beats broad exposure The details matter here..
How the Impact Factor Actually Works
Let's get technical for a moment. The impact factor is calculated by taking the total number of citations received by articles published in a journal during the previous two years, divided by the total number of citable items published in those same two years Not complicated — just consistent. Took long enough..
For IJID specifically, this means:
- Articles published in 2022 and 2023
- Citations to those articles received in 2024
- Divided by the total number of articles published in 2022 and 2023
The Numbers Game
As of the most recent data, IJID's impact factor sits around 5.5. Which means this puts it in the 35th-40th percentile among all medical journals, which sounds impressive until you realize that includes thousands of journals with much narrower scopes. Among infectious disease-specific journals, it ranks somewhere in the middle — not at the top, but definitely not at the bottom either.
The journal publishes roughly 300-400 articles per year, which gives you a sense of how competitive the acceptance rate might be. It's selective enough to maintain quality standards, but not so exclusive that you'll wait six months for a decision Still holds up..
Common Mistakes Researchers Make With IJID
I've seen smart researchers make the same errors over and over when evaluating journals like IJID. Here are the big ones:
Mistake #1: Obsessing Over the Impact Factor
Seriously, stop doing this. A single impactful paper can skew an entire journal's impact factor upward, while a few poorly received papers can drag it down. The impact factor is an average, and averages lie. What matters more is whether your specific paper reaches the audience that needs to read it Worth keeping that in mind..
Mistake #2: Ignoring the Editorial Process
IJID operates on a fairly standard peer review timeline — typically 4-6 weeks for initial decision, sometimes longer during peak submission periods. Some researchers assume faster review means lower quality, but that's not always true. The journal has maintained consistent quality standards while keeping turnaround times reasonable Simple, but easy to overlook..
Mistake #3: Underestimating Regional Citations
This is the big one. Here's the thing — papers published in IJID often get cited heavily within specific regions — Southeast Asia, Sub-Saharan Africa, Latin America — where local researchers are addressing similar public health challenges. These citations count toward the impact factor, but they might not show up in your Google Scholar alerts if you're only tracking Western databases.
Practical Tips for Publishing in IJID
If you're considering submitting to IJID, here's what actually works:
Know Your Audience
Before you write, ask yourself: does your research address a question that's particularly relevant to the regions and populations that IJID serves? Practically speaking, if you're studying malaria drug resistance in rural Kenya or cholera outbreak patterns in Bangladesh, you're speaking directly to IJID's core readership. If you're studying rare genetic conditions in Scandinavian populations, you might want to consider a different venue Still holds up..
Understand the Scope
IJID isn't looking for highly specialized basic science research or narrow clinical case reports. Day to day, they want papers that have broader public health implications. Even if your study is small, if it addresses a significant public health question, it has a chance Small thing, real impact..
Prepare for Regional Peer Review
Be ready for reviewers who might approach your work from perspectives you haven't considered. IJID's international reviewer pool means you might get feedback from researchers who are dealing with the same pathogens but under very different circumstances. This can actually improve your paper significantly.
FAQ About IJID's Impact Factor
Is IJID a good journal to publish in?
Yes, if your research aligns with their focus on global infectious diseases and public health. The impact factor of around 5.5 is solid, and the journal has good regional visibility It's one of those things that adds up..
How long does IJID take to publish?
Typically 4-6 months from submission to publication, including peer review time. This is fairly standard for mid-tier medical journals.
Is IJID indexed in PubMed?
Yes, IJID is indexed in PubMed/MEDLINE, which is crucial for visibility and citation potential Most people skip this — try not to. Worth knowing..
What's IJID's acceptance rate?
The journal doesn't publish official acceptance rates, but based on submission volume and publication frequency, it's likely around 20-30%.
How does IJID compare to other infectious disease journals?
It sits comfortably in the middle tier — below high-impact general medical journals like The Lancet or JAMA, but above many specialty journals. Its strength lies in its regional focus and global perspective.
The Bottom Line
Here's what I wish someone had told me when I was figuring out where to publish my own research: the impact factor is just one data point, and sometimes it's not even the most important one No workaround needed..
IJID's impact factor of around 5.On the flip side, 5 reflects a journal that's doing important work reaching researchers and clinicians who might not have access to other platforms. It's not going to give you the instant credibility boost of a higher-impact journal, but it might actually get your research into the hands of people who can use it.
And honestly? That's worth more than any number on a spreadsheet.
The real question isn't whether IJID has a good impact factor — it's whether your research belongs in a journal that serves the communities and populations you're trying to reach. For many infectious disease researchers working in global health, the answer is yes Most people skip this — try not to..
